1058 related articles for article (PubMed ID: 29705240)
1. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
2. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1.
Zeng S; Wu F; Chen M; Li Y; You M; Zhang Y; Yang P; Wei L; Ruan XZ; Zhao L; Chen Y
Antioxid Redox Signal; 2022 Jun; 36(16-18):1081-1100. PubMed ID: 35044230
[No Abstract] [Full Text] [Related]
4. Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production.
Li Y; Zhang L; Jiao J; Ding Q; Li Y; Zhao Z; Luo J; Chen Y; Ruan X; Zhao L
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166800. PubMed ID: 37423141
[TBL] [Abstract][Full Text] [Related]
5. KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7.
Yang S; Jia L; Xiang J; Yang G; Qiu S; Kang L; Zheng P; Liang Z; Lu Y
EMBO Rep; 2022 Jun; 23(6):e54229. PubMed ID: 35492028
[TBL] [Abstract][Full Text] [Related]
6. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.
Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
Toxicol Appl Pharmacol; 2017 Feb; 316():74-82. PubMed ID: 28038998
[TBL] [Abstract][Full Text] [Related]
8. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
[TBL] [Abstract][Full Text] [Related]
9. Alisol B Alleviates Hepatocyte Lipid Accumulation and Lipotoxicity via Regulating RARα-PPARγ-CD36 Cascade and Attenuates Non-Alcoholic Steatohepatitis in Mice.
Zhao Z; Deng ZT; Huang S; Ning M; Feng Y; Shen Y; Zhao QS; Leng Y
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745142
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM
Ding D; Ye G; Lin Y; Lu Y; Zhang H; Zhang X; Hong Z; Huang Q; Chi Y; Chen J; Dong S
Environ Pollut; 2019 May; 248():269-278. PubMed ID: 30798028
[TBL] [Abstract][Full Text] [Related]
11. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada P; González-Rodríguez Á; García-Monzón C; Valverde ÁM
Cell Death Dis; 2020 Sep; 11(9):802. PubMed ID: 32978374
[TBL] [Abstract][Full Text] [Related]
12. A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamsters.
Wang Y; Zhu Y; Niu J; Deng Q; Guo S; Jiang H; Peng Z; Xue Y; Peng H; Xuan L; Pan G
Toxicol Appl Pharmacol; 2020 Oct; 404():115169. PubMed ID: 32738331
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
[TBL] [Abstract][Full Text] [Related]
14. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
15. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
16. MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis.
Chanda D; Li J; Oligschlaeger Y; Jeurissen ML; Houben T; Walenbergh SM; Shiri-Sverdlov R; Neumann D
Exp Mol Med; 2016 Sep; 48(9):e258. PubMed ID: 27609031
[TBL] [Abstract][Full Text] [Related]
17. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
18. β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats.
Luo H; Xu N; Wu J; Gan Y; Chen L; Guan F; Li M; Li Y; Chen J; Su Z; Liu Y
Int Immunopharmacol; 2021 Sep; 98():107915. PubMed ID: 34198236
[TBL] [Abstract][Full Text] [Related]
19. Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis.
Du J; Zhang X; Han J; Man K; Zhang Y; Chu ES; Nan Y; Yu J
Theranostics; 2017; 7(17):4192-4203. PubMed ID: 29158819
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis.
Huang C; Liu Q; Tang Q; Jing X; Wu T; Zhang J; Zhang G; Zhou J; Zhang Z; Zhao Y; Huang H; Xia Y; Yan J; Xiao J; Li Y; He J
Free Radic Biol Med; 2021 Jun; 169():110-121. PubMed ID: 33857628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
